If you can tolerate the GI burden and want maximum weight loss, the retatrutide dosing chart delivers substantially more results per milligram of discomfort
To learn more about emerging telehealth trends and compliance strategies, explore our Telehealth Insights hub and subscribe to our newsletter.
At 16 weeks: 100% response rate in multiple endpoints at the 45 mg dose Rapid separation from placebo as early as Week 4 Clear dose-dependent efficacy signal 2 Clinically meaningful, not just statistically significant Key efficacy highlights: CSAMI-A score: 45 mg: 22.3 points Placebo: 0.7 points 100% of patients on 45 mg achieved a 10-point clinically meaningful improvement 69% achieved near-clear or clear skin on Investigators Global Assessment 3 External validation from clinical leaders Misha Rosenbach, M.D
Both No DAC and With DAC formulations are verified independently
Two large phase 3 trials independently reached the same negative clinical result
For these reasons, comparing rates of hypoglycemia in clinical trials for TOUJEO with the incidence of hypoglycemia for other products may be misleading and also may not be representative of hypoglycemia rates that will occur in clinical practice